Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
- PMID: 33828996
- PMCID: PMC8020595
- DOI: 10.3389/fonc.2021.675806
Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
Abstract
[This corrects the article DOI: 10.3389/fonc.2020.581814.].
Keywords: P-gp; angiogenesis; drug resistance; glioblastoma; mifepristone; temozolomide.
Copyright © 2021 Llaguno-Munive, León-Zetina, Vazquez-Lopez, Ramos-Godinez, Medina and Garcia-Lopez.
Figures
Erratum for
-
Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide.Front Oncol. 2020 Oct 5;10:581814. doi: 10.3389/fonc.2020.581814. eCollection 2020. Front Oncol. 2020. PMID: 33123485 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources